MyintSH. Human coronaviruses: A brief review. Rev Med Virol, 1994; 4(1):35–46; doi: 10.1002/rmv.1980040108
2.
GagneurA, SizunJ, ValletS, et al.Coronavirus-related nosocomial viral respiratory infections in a neonatal and paediatric intensive care unit: A prospective study. J Hosp Infect, 2002; 51(1):59–64; doi: 10.1053/jhin.2002.1179
3.
Mesel-LemoineM, MilletJ, VidalainPO, et al.A human coronavirus responsible for the common cold massively kills dendritic cells but not monocytes. J Virol, 2012; 86(14):7577–7587; doi: 10.1128/JVI.00269-12
4.
PaulesCI, MarstonHD, FauciAS. Coronavirus infections-More than just the common cold. JAMA, 2020; 323(8):707–708; doi: 10.1001/jama.2020.0757
5.
HamreD, ProcknowJJ. A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med, 1966; 121(1):190–193; doi: 10.3181/00379727-121-30734
6.
van der HoekL, PyrcK, JebbinkMF, et al.Identification of a new human coronavirus. Nat Med, 2004; 10(4):368–373; doi: 10.1038/nm24
7.
van der HoekL, PyrcK, BerkhoutB. Human coronavirus NL63, a new respiratory virus. FEMS Microbiol Rev, 2006; 30(5):760–773; doi: 10.1111/j.574–6976.2006.00032.x
8.
McIntoshK, DeesJH, BeckerWB, et al.Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A, 1967; 57(4):933–940; doi: 10.1073/pnas.57.4.933
9.
WooPC, LauSK, ChuCM, et al.Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol, 2005; 79(2):884–895; doi: 10.1128/JVI.79.2.884–895.2005
GrifoniA, WeiskopfD, RamirezSI, et al.Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell, 2020; 181(7):1489–1501.e15; doi: 10.016/j.cell.2020.05.015
12.
MateusJ, GrifoniA, TarkeA, et al.Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science, 2020; 370(6512):89–94; doi: 10.1126/science.abd3871
13.
Le BertN, TanAT, KunasegaranK, et al.SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature, 2020; 584(7821):457–462; doi: 10.1038/s41586-020-2550-z
14.
KunduR, NareanJS, WangL, et al.Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts. Nat Commun, 2022; 13(1):80; doi: 10.1038/s41467-021-27674-x
15.
LeggeKL, BracialeTJ. Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity, 2003; 18(2):265–277; doi: 10.1016/s74-7613(03)00023-2
